Acta Crystallographica Section D Biological Crystallography · 2007 · 14 citations · 9 references
Life SciencesBiochemistryMolecular BiologyDrug DesignEnzymologyStructural BiologyEnzyme Active SitesEnzyme InhibitionEnzyme KineticsEnzyme StabilityEnzyme StabilizationProtein DynamicsActive Site MechanismsCatalytic Site ArchitectureDrug Target ValidationEnzyme ActivityEnzyme Activity RegulationEnzyme Activity RetentionEnzyme Stabilization MechanismsMycobacterium Tuberculosis Infection
The MabA protein from Mycobacterium tuberculosis is a validated drug target. Previous structural studies of this protein showed dynamic behaviour in the catalytic site and described motion between an open 'active' holo form (with NADP) and a closed 'inactive' apo form (without NADP). Here, a mutation (G139A) is reported that leads to complete protein inactivation and freezes the catalytic site into its closed form, even in the presence of the cofactor. This observation suggests a new way to develop anti-MabA drugs via protein stabilization of the 'inactive' form.
9